Literature DB >> 20084219

Canadian directions for enhancing drug discovery and investigation in children: A brighter future.

D Matsui1, M J Rieder.   

Abstract

Entities:  

Year:  2001        PMID： 20084219      PMCID： PMC2804522          DOI： 10.1093/pch/6.3.123

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  5 in total

1.  The Pediatric Pharmacology Research Unit (PPRU) Network and its role in meeting pediatric labeling needs.

Authors:  S N Cohen
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

2.  Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.

Authors: 
Journal:  Fed Regist       Date:  1998-12-02

3.  Therapeutic orphans.

Authors:  H Shirkey
Journal:  J Pediatr       Date:  1968-01       Impact factor: 4.406

4.  Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs, American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  1995-02       Impact factor: 7.124

5.  Status of drug approval processes and regulation of medications for children.

Authors:  R E Kauffman
Journal:  Curr Opin Pediatr       Date:  1995-04       Impact factor: 2.856
  5 in total
  1 in total

1.  Better drug therapy for children: Time for action.

Authors:  Michael J Rieder
Journal:  Paediatr Child Health       Date:  2003-04       Impact factor: 2.253
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.